Targeting Senescence. Ageing,

Redefined.

Senesys.Bio™ is transforming the treatment of age-related diseases through NanoJAGGs™, a novel nanostructure-based delivery platform that targets and eliminates senescent cells, the root cause of over 100 chronic conditions.

Advancing Precision Therapeutics with

NanoJAGGs™

NanoJAGGs™ are tiny, biocompatible nanostructures that selectively detect and deliver therapies to senescent cells, targeting the root cause of aging and age-related diseases.

NanoJAGGs™ unlock incredible potential by enabling both the precise removal of harmful senescent cells and the restoration of healthy tissue function, paving the way for safer and more effective treatments.

Advanced Targeting Technology

NanoJAGGs™ naturally localise to senescent cells due to their interaction with senescent cellular organelles and metabolic features, achieving high selectivity without the need for added antibodies or chemical modifications.

Unparalleled Versatility by Design

NanoJAGGs™ can be tailored to carry a wide range of therapeutic molecules, from natural senolytics and antioxidants to small drugs and biomolecules. This flexibility allows each formulation to be customised for different diseases and applications, creating a single platform adaptable to multiple therapeutic needs.

Pioneering Therapeutic Delivery

NanoJAGGs™ are engineered to carry therapeutic agents that are released only within senescent cells. This selective activation ensures that treatments act precisely where they are needed, minimising harm to healthy tissue and enhancing overall safety and efficacy.

Power in the Nanoscale

At just around 30 nanometres, NanoJAGGs™ are small enough to navigate deep within tissues and reach areas that are often inaccessible to conventional therapies. Their nanoscale size enables efficient penetration and precise interaction with senescent cells, ensuring targeted action where it matters most.